Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy

Huan Xu, Junyi Chen, Zhi Cao, Xi Chen, Caihong Huang, Jin Ji, Yalong Xu, Junfeng Jiang, Yue Wang, Guowang Xu, Lina Zhou, Jingyi He, Xuedong Wei, Jason Boyang Wu, Zhong Wang, Shancheng Ren and Fubo Wang
Cancer Biology & Medicine September 2022, 19 (9) 1315-1333; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0638
Huan Xu
1Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China
2Department of Urology, Shanghai Ninth People’s Hospital, Shanghai 200011, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junyi Chen
3Department of Urology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi Cao
1Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xi Chen
1Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China
4Department of Urology, No. 971 Hospital of the People’s Liberation Army Navy, Qingdao 266000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caihong Huang
5Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Ji
1Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yalong Xu
1Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junfeng Jiang
6Research Center of Developmental Biology, Second Military Medical University, Shanghai 200433, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yue Wang
6Research Center of Developmental Biology, Second Military Medical University, Shanghai 200433, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guowang Xu
7Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lina Zhou
7Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingyi He
8Department of Urology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuedong Wei
8Department of Urology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Boyang Wu
9Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA 99202, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhong Wang
2Department of Urology, Shanghai Ninth People’s Hospital, Shanghai 200011, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shancheng Ren
1Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shancheng Ren
  • For correspondence: [email protected] [email protected]
Fubo Wang
5Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fubo Wang
  • For correspondence: [email protected] [email protected]
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 19 no. 9 1315-1333
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2021.0638

Published By 
Cancer Biology & Medicine
History 
  • Received November 29, 2021
  • Accepted March 2, 2022
  • Published online September 22, 2022.

Article Versions

  • previous version (August 24, 2022 - 05:21).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Huan Xu1,2,*,
  2. Junyi Chen3,*,
  3. Zhi Cao1,
  4. Xi Chen1,4,
  5. Caihong Huang5,
  6. Jin Ji1,
  7. Yalong Xu1,
  8. Junfeng Jiang6,
  9. Yue Wang6,
  10. Guowang Xu7,
  11. Lina Zhou7,
  12. Jingyi He8,
  13. Xuedong Wei8,
  14. Jason Boyang Wu9,
  15. Zhong Wang2,
  16. Shancheng Ren1⇑ and
  17. Fubo Wang5⇑
  1. 1Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China
  2. 2Department of Urology, Shanghai Ninth People’s Hospital, Shanghai 200011, China
  3. 3Department of Urology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China
  4. 4Department of Urology, No. 971 Hospital of the People’s Liberation Army Navy, Qingdao 266000, China
  5. 5Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, China
  6. 6Research Center of Developmental Biology, Second Military Medical University, Shanghai 200433, China
  7. 7Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China
  8. 8Department of Urology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
  9. 9Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA 99202, USA
  1. Correspondence to: Fubo Wang and Shancheng Ren, E-mail: wangfubo{at}gxmu.edu.cn and renshancheng{at}gmail.com
View Full Text
PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 19 (9)
Cancer Biology & Medicine
Vol. 19, Issue 9
15 Sep 2022
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
Huan Xu, Junyi Chen, Zhi Cao, Xi Chen, Caihong Huang, Jin Ji, Yalong Xu, Junfeng Jiang, Yue Wang, Guowang Xu, Lina Zhou, Jingyi He, Xuedong Wei, Jason Boyang Wu, Zhong Wang, Shancheng Ren, Fubo Wang
Cancer Biology & Medicine Sep 2022, 19 (9) 1315-1333; DOI: 10.20892/j.issn.2095-3941.2021.0638

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
Huan Xu, Junyi Chen, Zhi Cao, Xi Chen, Caihong Huang, Jin Ji, Yalong Xu, Junfeng Jiang, Yue Wang, Guowang Xu, Lina Zhou, Jingyi He, Xuedong Wei, Jason Boyang Wu, Zhong Wang, Shancheng Ren, Fubo Wang
Cancer Biology & Medicine Sep 2022, 19 (9) 1315-1333; DOI: 10.20892/j.issn.2095-3941.2021.0638
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Conclusions
    • Supporting Information
    • Availability of data and material
    • Grant support
    • Conflict of interest statement
    • Author contributions
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer
  • Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy
  • Combined chemo-endocrine therapy as a potential new option for HR+/HER2− advanced breast cancer: a prospective study of fulvestrant plus oral vinorelbine
Show more Original Article

Similar Articles

Keywords

  • Glycolytic potential
  • prostate cancer
  • mitochondrial pyruvate carrier (MPC)
  • mitochondria pyruvate influx
  • diagnosis
  • radiotherapy

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire